News

Fierce Pharma15h
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
Single-dose vaccine demonstrates sustained efficacy against RSV-related lower respiratory tract disease in older adults
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
A parent’s worst nightmare: RSV
Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our infants with vaccination.
pharmaphorum20h
There's good news for RSV jab firms at delayed ACIP meeting
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
News-Medical.Net on MSN6d
RSV-associated infections linked to higher one year mortality in adults
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...
The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted ...
Healio4d
RSV triples a person’s risk for death within 1 year, study shows
After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...